These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4807169)

  • 1. [Hemodynamic effects of metaproterenol in congenital heart diseases with pulmonary hypertension].
    Azzolina G; Ferrara GB; Macrì R; Pasquè A; Pensa P; Redaelli S
    Boll Soc Ital Cardiol; 1973; 18(9):849-53. PubMed ID: 4807169
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamics after beta-receptor blockade].
    Stauch M; Schairer K
    Z Kreislaufforsch; 1969 Jun; 58(6):586-92. PubMed ID: 5799933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Surgical treatment of congenital heart defects with pulmonary hypertension--with special reference to hemodynamic changes caused by the operation].
    Toriyama A
    Nihon Kyobu Geka Gakkai Zasshi; 1973 Oct; 21(10):943-68. PubMed ID: 4798666
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension.
    Singh R; Choudhury M; Saxena A; Kapoor PM; Juneja R; Kiran U
    J Cardiothorac Vasc Anesth; 2010 Oct; 24(5):797-801. PubMed ID: 20056439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of nitroglycerin on hemodynamics in patients with congenital heart defects associated with and without pulmonary hypertension].
    Chepkiĭ LP; Shubin MK; Panichkin IuV; Brusan LA
    Ter Arkh; 1972 Jan; 44(1):48-54. PubMed ID: 4622805
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemodynamic effects of tolazoline. Studies in normal subjects and patients with mitral valvular disease, congenital heart disease and primary pulmonary hypertension.
    Abrahamsen AM; Grendahl H; Müller C
    Acta Med Scand; 1971 Sep; 190(3):199-203. PubMed ID: 5120969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lung biopsy in the congenital cardiac anomalies associated with pulmonary hypertension--evaluation of pulmonary vascular changes and determination of surgical indication (author's transl)].
    Yamaki S; Kagawa Y; Ishizawa E; Suzuki Y; Sato S; Kahata O; Horiuchi T
    Kyobu Geka; 1981 Apr; 34(4):252-7. PubMed ID: 7265567
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postoperative follow-up of congenital heart diseases with pulmonary hypertension].
    Ando T; Washio M; Irisawa T; Matsukawa T; Kasuya S
    Nihon Kyobu Geka Gakkai Zasshi; 1972 May; 20(5):398-402. PubMed ID: 4676525
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of inhaled nitric oxide in patients with pulmonary hypertension].
    Zhao Y; Zhao Y; Chen B
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):287-90, 320. PubMed ID: 7656163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metaproterenol (orciprenaline) in the treatment of the symptomatic complete heart block.
    De Saint Pierre G
    Mal Cardiovasc; 1968; 9(1):135-43. PubMed ID: 5736665
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of pulmonary hypertension in congenital heart defects in childhood].
    Beuren AJ
    Klin Padiatr; 1972 Jan; 184(1):1-3. PubMed ID: 5063475
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the pulmonary artery in secondary pulmonary hypertension with special regard to hypertensive necrotizing arteritis].
    Geroulanos S
    Pathol Eur; 1970; 5(4):384-400. PubMed ID: 4396718
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary hypertension--hemodynamic and clinical examples of some congenital heart defect].
    Keck EW
    Med Klin; 1966 Mar; 61(9):325-30. PubMed ID: 5986157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pulmonary hypertension associated with congenital heart disease (author's transl)].
    Momma K
    Kokyu To Junkan; 1982 Jun; 30(6):554-62. PubMed ID: 7051210
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lung tissue biopsy in patients with congenital heart defects and severe pulmonary hypertension].
    Suslov EI; Gushla EP; Podgaevskaia TP
    Vrach Delo; 1986 Jul; (7):37-9. PubMed ID: 3750994
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
    Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
    Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
    Pan S; Xiao M; Liu Y
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrocardiographic evaluation of pulmonary hypertension in children with shunts].
    Borkowska K
    Kardiol Pol; 1971; 14(2):123-9. PubMed ID: 5095308
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surgical management and results in congenital heart diseases with pulmonary hypertension].
    Shohtsu A; Takeuchi S; Sohma Y; Koide S; Imamura H
    Kyobu Geka; 1975 Feb; 28(2):77-86. PubMed ID: 1168815
    [No Abstract]   [Full Text] [Related]  

  • 20. Possibilities and impossibilities in the evaluation of pulmonary vascular disease in congenital heart defects.
    Berger RM
    Eur Heart J; 2000 Jan; 21(1):17-27. PubMed ID: 10610739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.